OPEN LETTER TO LEGISLATORS REGARDING FETAL CELL DNA IN VACCINES
April 8, 2019
My name is Dr. Theresa Deisher. I am Founder and Lead Scientist at Sound Choice Pharmaceutical Institute, whose mission is to educate the public about vaccine safety, as well as to pressure manufacturers to provide better and safer vaccines for the public. I obtained my doctorate from Stanford University in Molecular and Cellular Physiology in 1990 and completed my post-doctoral work at the University of Washington. My career has been spent in the commercial biotechnology industry, and I have done work from basic biological and drug discovery through clinical development.
I am writing regarding unrefuted scientific facts about fetal DNA contaminants in the Measles-Mumps-Rubella vaccine, which must be made known to lawmakers and the public.
READ OPEN LETTER
Dr. Theresa Deisher
Human fetal DNA introduced with vaccines may be taken up via cellular DNA uptake receptors or may spontaneously penetrate cell membranes that have become permeable during inflammatory reactions, study says.
A trio of recent publications in the journal NEURON reports the presence of hundreds of diverse de novo gene mutations indicating that autism spectrum disorder (ASD) may be a disease of genomic instability, with a significant environmental component. Altered double strand break formation and repair pathways (DSB) may be a commonality among the diverse genetic mutations that have been documented in ASD. US birthyear changepoints in AD are apparent in 1980, 1988 and 1996, coinciding with the switch to or introduction of childhood vaccines contaminated with human endogenous retrovirus K (HERVK) and human fetal DNA fragments. The HERVK and human fetal DNA contaminants could contribute to the genomic instability of ASD demonstrated by de novo mutations. Read more…